CC-BY-NC-ND 4.0 · JCS 2018; 08(01): e43-e45
DOI: 10.1055/s-0038-1655752
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Growth Hormone Deficiency in Congenital Toxoplasmosis

Juma Natsheh
1  Department of Pediatrics, Endocrinology Unit, Makassed Islamic Hospital, Jerusalem, Israel
,
Bassam Abu-Libdeh
1  Department of Pediatrics, Endocrinology Unit, Makassed Islamic Hospital, Jerusalem, Israel
,
Abdulsalam Abu-Libdeh
1  Department of Pediatrics, Endocrinology Unit, Makassed Islamic Hospital, Jerusalem, Israel
› Author Affiliations
Further Information

Publication History

19 June 2017

18 April 2018

Publication Date:
25 May 2018 (online)

Abstract

Congenital toxoplasmosis represents the second most commonly recognized congenital infection. Ocular and neurological abnormalities are considered the most frequent sequelae. Endocrinological manifestations are rare and have received little attention. We report a 3.5-month-old female infant who presented with failure to thrive and recurrent hypoglycemic attacks, diagnosed as growth hormone deficiency due to sequelae of congenital toxoplasmosis. Although endocrinological sequelae of congenital toxoplasmosis are uncommon, they represent potentially treatable conditions. Here, we stress on the importance of monitoring pituitary function and growth in children in particular, with congenital toxoplasmosis, keeping in mind other possible, potentially treatable, endocrinological manifestations.